191 related articles for article (PubMed ID: 31020747)
41. Effect of venous ulcer exudates on angiogenesis in vitro.
Drinkwater SL; Smith A; Sawyer BM; Burnand KG
Br J Surg; 2002 Jun; 89(6):709-13. PubMed ID: 12027980
[TBL] [Abstract][Full Text] [Related]
42. Effectiveness and tissue compatibility of a 12-week treatment of chronic venous leg ulcers with an octenidine based antiseptic--a randomized, double-blind controlled study.
Vanscheidt W; Harding K; Téot L; Siebert J
Int Wound J; 2012 Jun; 9(3):316-23. PubMed ID: 22074592
[TBL] [Abstract][Full Text] [Related]
43. Clinical performance of a new silver dressing, Contreet Foam, for chronic exuding venous leg ulcers.
Karlsmark T; Agerslev RH; Bendz SH; Larsen JR; Roed-Petersen J; Andersen KE
J Wound Care; 2003 Oct; 12(9):351-4. PubMed ID: 14601228
[TBL] [Abstract][Full Text] [Related]
44. Accelerated wound healing: multidisciplinary advances in the care of venous leg ulcers.
Bongiovanni CM; Hughes MD; Bomengen RW
Angiology; 2006; 57(2):139-44. PubMed ID: 16518520
[TBL] [Abstract][Full Text] [Related]
45. Early healing rates and wound area measurements are reliable predictors of later complete wound closure.
Cardinal M; Eisenbud DE; Phillips T; Harding K
Wound Repair Regen; 2008; 16(1):19-22. PubMed ID: 18211575
[TBL] [Abstract][Full Text] [Related]
46. Role of matrix metalloproteinases in non-healing venous ulcers.
Amato B; Coretti G; Compagna R; Amato M; Buffone G; Gigliotti D; Grande R; Serra R; de Franciscis S
Int Wound J; 2015 Dec; 12(6):641-5. PubMed ID: 24164799
[TBL] [Abstract][Full Text] [Related]
47. Honey as a topical treatment for wounds.
Jull AB; Rodgers A; Walker N
Cochrane Database Syst Rev; 2008 Oct; (4):CD005083. PubMed ID: 18843679
[TBL] [Abstract][Full Text] [Related]
48. Surrogate endpoints for the treatment of venous leg ulcers.
Gelfand JM; Hoffstad O; Margolis DJ
J Invest Dermatol; 2002 Dec; 119(6):1420-5. PubMed ID: 12485449
[TBL] [Abstract][Full Text] [Related]
49. Senescence and the healing rates of venous ulcers.
Stanley A; Osler T
J Vasc Surg; 2001 Jun; 33(6):1206-11. PubMed ID: 11389419
[TBL] [Abstract][Full Text] [Related]
50. Comparing the efficacies of alginate, foam, hydrocolloid, hydrofiber, and hydrogel dressings in the management of diabetic foot ulcers and venous leg ulcers: a systematic review and meta-analysis examining how to dress for success.
Saco M; Howe N; Nathoo R; Cherpelis B
Dermatol Online J; 2016 Aug; 22(8):. PubMed ID: 27617934
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of wound fluid biomarkers to determine healing in adults with venous leg ulcers: A prospective study.
Stacey M; Farrokhyar F
Wound Repair Regen; 2020 Jan; 28(1):158. PubMed ID: 31774597
[No Abstract] [Full Text] [Related]
52. Clinical use of cold atmospheric pressure argon plasma in chronic leg ulcers: A pilot study.
Ulrich C; Kluschke F; Patzelt A; Vandersee S; Czaika VA; Richter H; Bob A; Hutten Jv; Painsi C; Hüge R; Kramer A; Assadian O; Lademann J; Lange-Asschenfeldt B
J Wound Care; 2015 May; 24(5):196, 198-200, 202-3. PubMed ID: 25970756
[TBL] [Abstract][Full Text] [Related]
53. [Protein expressions of matrix metalloproteinase-9 and its inhibitor and their ratio changes in wound healing of patients with stages Ⅲ and Ⅳ pressure ulcers].
Wang Y; Li X; Zhao W; Gao ZZ; Zheng MJ; Pang YL; Chen ZY
Zhonghua Shao Shang Za Zhi; 2019 Oct; 35(10):746-751. PubMed ID: 31658546
[No Abstract] [Full Text] [Related]
54. The accuracy of venous leg ulcer prognostic models in a wound care system.
Margolis DJ; Allen-Taylor L; Hoffstad O; Berlin JA
Wound Repair Regen; 2004; 12(2):163-8. PubMed ID: 15086767
[TBL] [Abstract][Full Text] [Related]
55. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers.
Nwomeh BC; Liang HX; Cohen IK; Yager DR
J Surg Res; 1999 Feb; 81(2):189-95. PubMed ID: 9927539
[TBL] [Abstract][Full Text] [Related]
56. Dressings for healing venous leg ulcers.
Palfreyman SJ; Nelson EA; Lochiel R; Michaels JA
Cochrane Database Syst Rev; 2006 Jul; (3):CD001103. PubMed ID: 16855958
[TBL] [Abstract][Full Text] [Related]
57. Quality control in chronic wound management: the role of local povidone-iodine (Betadine) therapy.
Daróczy J
Dermatology; 2006; 212 Suppl 1():82-7. PubMed ID: 16490980
[TBL] [Abstract][Full Text] [Related]
58. Effect of a New Purified Collagen Matrix With Polyhexamethylene Biguanide on Recalcitrant Wounds of Various Etiologies: A Case Series.
Lintzeris D; Vernon K; Percise H; Strickland A; Yarrow K; White A; Gurganus M; Sherrod S; Vergin K; Johnson L
Wounds; 2018 Mar; 30(3):72-78. PubMed ID: 29584602
[TBL] [Abstract][Full Text] [Related]
59. Effect of chronic wound fluid on fibroblasts.
Phillips TJ; Al-Amoudi HO; Leverkus M; Park HY
J Wound Care; 1998 Nov; 7(10):527-32. PubMed ID: 10188448
[TBL] [Abstract][Full Text] [Related]
60. Iron and 8-isoprostane levels in acute and chronic wounds.
Yeoh-Ellerton S; Stacey MC
J Invest Dermatol; 2003 Oct; 121(4):918-25. PubMed ID: 14632213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
